Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

This medicine may be one of the best tools doctors have to fight the fentanyl crisis. Preparation of a dose of Buprenorphine, ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.

A recent study explodes the myth that the risk of addiction to prescription opioids exists only among patients abusing their opioids. Until recently, the National Survey on Drug Use and Health ...

There are various definitions for opioid abuse. The consensus statement from the American Pain Society, the American Association of Pain Management, and the American Society of Addiction Medicine ...

A study showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia. A study conducted at Turku PET Centre in Finland showed that changes in the ...

“The Sackler family relentlessly pursued profit at the expense of vulnerable patients, and played a critical role in starting and fuelling the opioid epidemic,” James said in the statement.

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

U.S. Bankruptcy Judge Sean Lane, who is overseeing Purdue's Chapter 11 proceedings, said the company is making concrete progress toward a deal and approved its request to pause all opioid lawsuits ...

The owners of Purdue Pharma, which makes OxyContin, have agreed to pay US7.4 billion ($11.7 billion) to settle lawsuits over the toll of the powerful prescription painkiller. The Sackler family ...

(AP Photo/Douglas Healey, File) New York Attorney General Letitia James speaks about a settlement with regard to the opioid crisis at a news conference in New York, Thursday, Jan. 23, 2025. (AP ...